|Articles|March 1, 2020
- Pharmaceutical Executive-03-01-2020
- Volume 40
- Issue 3
Pharmaceutical Executive, March 2020 Issue (PDF)
Click the title above to open the Pharmaceutical Executive March 2020 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
The Multichannel Reach: Balancing the Local and Global Voiceabout 6 years ago
Market Access: From Being to Becomingabout 6 years ago
Consider Data Before It’s a Problemabout 6 years ago
Multichannel Marketing: Integrating Omnichannelabout 6 years ago
Feds Target Biosimilar Anticompetitive Practicesabout 6 years ago
Blood Feud Divides Europe Over Plasma Shortfallsabout 6 years ago
Social Media’s Influence in Messaging Mixabout 6 years ago
Habib Bennaceur: Following the Scienceabout 6 years ago
A Bad Deal with Data?about 6 years ago
Country Report: United Arab EmiratesNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees
Published: | Updated:
Advertisement
Advertisement